Sign in Sign up for free

Last updated: 2 July 2019 at 2:12am EST

Len F Stigliano Net Worth




The estimated Net Worth of Len F Stigliano is at least $123 Thousand dollars as of 24 August 2007. Len Stigliano owns over 10,000 units of Novavax stock worth over $122,900 and over the last 17 years Len sold NVAX stock worth over $0.

Len Stigliano NVAX stock SEC Form 4 insiders trading

Len has made over 1 trades of the Novavax stock since 2007, according to the Form 4 filled with the SEC. Most recently Len bought 10,000 units of NVAX stock worth $31,400 on 24 August 2007.

The largest trade Len's ever made was buying 10,000 units of Novavax stock on 24 August 2007 worth over $31,400. On average, Len trades about 2,500 units every 0 days since 2007. As of 24 August 2007 Len still owns at least 10,000 units of Novavax stock.

You can see the complete history of Len Stigliano stock trades at the bottom of the page.



What's Len Stigliano's mailing address?

Len's mailing address filed with the SEC is C/O NOVAVAX, INC., 9920 BELWARD CAMPUS DRIVE, ROCKVILLE, MD, 20850.

Insiders trading at Novavax

Over the last 23 years, insiders at Novavax have traded over $136,088,511 worth of Novavax stock and bought 2,908,869 units worth $5,634,467 . The most active insiders traders include David M Mott, Rajiv I. Modi, and Gary C Evans. On average, Novavax executives and independent directors trade stock every 25 days with the average trade being worth of $907,678. The most recent stock trade was executed by John Trizzino on 19 August 2024, trading 655 units of NVAX stock currently worth $8,050.



What does Novavax do?

novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.



What does Novavax's logo look like?

Novavax, Inc. logo

Complete history of Len Stigliano stock trades at Novavax

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
24 Aug 2007 NVAX Novavax, Inc. Len F Stigliano
Vice President, CFO, and Treasurer
 Buy 10,000 $3.14 $31,400
24 Aug 2007
10,000 ↗


Novavax executives and stock owners

Novavax executives and other stock owners filed with the SEC include: